In addition, glioblastoma and RRMS patients shared higher fractions of KLRG1+ CD4+ TTE, whereas CD8+ effector and memory Tc were only elevated in RRMS patients compared to controls. The gene discussed is CD4; the disease is relapsing-remitting multiple sclerosis.